(Q41581748)

4 October 2017

1 reference

title

A two-process theory of schizophrenia: evidence from studies in post-mortem brain (English)

1 reference

4 October 2017

0 references

Deakin JF

1

1 reference

4 October 2017

Simpson MD

series ordinal

2

1 reference

4 October 2017

publication date

1 March 1997

1 reference

Journal of Psychiatric Research

4 October 2017

published in

1 reference

4 October 2017

volume

31

1 reference

4 October 2017

issue

2

1 reference

4 October 2017

page(s)

277-295

1 reference

GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased Density of Glutamate-immunoreactive Vertical Processes in Superficial Laminae in Cingulate Cortex of Schizophrenic Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Glutamic-acid decarboxylase in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic Autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Recent advances in the neuropathology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

An open trial of glycine as an adjunct to neuroleptics in chronic treatment-refractory schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Gamma-aminobutyric acid in the brain in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

A randomised controlled trial of prophylactic neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Neuropsychological implications of brain changes in schizophrenia: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Hyperinnervation of orbital frontal cortex in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

History and pharmacology of PCP and PCP-related analogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Cell loss in the hippocampus of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Glutamate: A Neurotransmitter in Mammalian Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

The left medial temporal region and schizophrenia. A PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

The Interaction Between GABA and Dopamine: Implications for Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Glutamate in schizophrenics and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Hippocampal neuron number in schizophrenia. A stereological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

NMDA-associated glycine binding site increases in schizophrenic brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Amelioration of negative symptoms in schizophrenia by glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Hippocampal pathologic findings in schizophrenia. A morphometric study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Changes in caudate volume with neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Cerebrospinal fluid amino acid concentrations in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Neurotransmitter amino acids in post-mortem brains of chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Free amino acid level determinations in normal and schizophrenic brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

A pet study of obligate carriers of the predisposition to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Duration of psychosis and outcome in first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased brain dopamine and dopamine receptors in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased dopamine-receptor sensitivity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Schizophrenia, tardive dyskinesia, and brain GABA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Hippocampal benzodiazepine receptors in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

The relative abundance of dopamine D4 receptor mRNA in post mortem brains of schizophrenics and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Dopamine D4 receptors elevated in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Evidence of glutamatergic deficiency in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

From neuropathology to neurodevelopment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Tritiated LSD Binding in Frontal Cortex in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Volumetric MRI assessment of temporal lobe structures in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

Allosteric modulation of N-methyl-D-aspartate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Reduced GABA uptake sites in the temporal lobe in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900042-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(96)00042-8

1 reference

4 October 2017

1 reference